Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Allergy and Asthma Proceedings|April 12, 2011
Comprehensive report of olopatadine 0.6% nasal spray as treatment for children with seasonal allergic rhinitisEli O Meltzer, Michael Blaiss, Carol J FairchildCornea|November 4, 2010
The economic burden of dry eye disease in the United States: a decision tree analysisJunhua Yu, Carl V Asche, Carol J FairchildAmerican Journal of Rhinology & Allergy|June 7, 2011
Outcomes and cost comparison of three therapeutic approaches to allergic rhinitisCarol J Fairchild, Emily Durden, Zhun Cao, et al.Optometry and Vision Science : Official Publication of the American Academy of Optometry|August 5, 2008
Clinically important difference in dry eye: change in IDEEL-symptom botherCarol J Fairchild, Robin L Chalmers, Carolyn G BegleyAllergy and Asthma Proceedings|January 19, 2008
Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitisCarol J Fairchild, Eli O Meltzer, Peter S Roland, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 2, 2008
Medication compliance and persistence: terminology and definitionsJoyce A Cramer, Anuja Roy, Anita Burrell, et al.Allergy and Asthma Proceedings|August 18, 2006
Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placeboFrank C Hampel, Paul H Ratner, Niran J Amar, et al.Pageof 1